SEC Form D · filed January 10, 2018
Carmell Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Richard Upton · Pittsburgh, PADirectorJames J. Hart · Hershey, PAExecStephanie W. Kladakis · Pittsburgh, PAExecRandolph Hubbell · Pittsburgh, PAExec · DirectorDavid W. Anderson · Pittsburgh, PADirectorJames F. Jordan · Pittsburgh, PADirectorDonna Godward · Pittsburgh, PAExecJames Connolly · Los Angeles, CAExec · DirectorJustin Fallon · Los Angeles, CADirectorAlex R. Duncan · Lexington, MAExecChristian R. Cortis · Lexington, MAExecJay Venkatesan · Los Angeles, CAExecMichael Meyers · Los Angeles, CADirectorEvan R. Kearns · Lexington, MADirectorAndrew W. Dym · New York, NYExecDavid W. Schiff · New York, NYDirectorJoseph W. Schottland · New York, NYDirectorMax Lin · MENLO PARK, CAExec · DirectorJim Momtazee · MENLO PARK, CAExecMark Bisso · HOUSTON, TXExecAndrew J. Duffy · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗